View in EDS

MIRASOL: A randomized, open-label, phase 3 study of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression (297)

Saved in:
Bibliographic Details
Title: MIRASOL: A randomized, open-label, phase 3 study of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression (297)
Authors: Moore, Kathleen1 (AUTHOR), Konecny, Gottfried2 (AUTHOR), Martin, Lainie3 (AUTHOR), Floquet, Anne4 (AUTHOR), O'Malley, David5 (AUTHOR), Colombo, Nicoletta6 (AUTHOR), Mantia-Smaldone, Gina7 (AUTHOR), Banerjee, Susana8 (AUTHOR), Gilbert, Lucy9 (AUTHOR), de Gregorio, Nikolaus10 (AUTHOR), Tromp, Jacqueline11 (AUTHOR), Wang, Jiuzhou12 (AUTHOR), Esteves, Brooke12 (AUTHOR), Method, Michael12 (AUTHOR), Van Gorp, Toon13 (AUTHOR)
Source: Gynecologic Oncology. 2022 Supplement 1, Vol. 166, pS156-S157. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 159029634
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MIRASOL: A randomized, open-label, phase 3 study of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression (297)
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Moore%2C+Kathleen%22">Moore, Kathleen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Konecny%2C+Gottfried%22">Konecny, Gottfried</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martin%2C+Lainie%22">Martin, Lainie</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Floquet%2C+Anne%22">Floquet, Anne</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22O'Malley%2C+David%22">O'Malley, David</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Colombo%2C+Nicoletta%22">Colombo, Nicoletta</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mantia-Smaldone%2C+Gina%22">Mantia-Smaldone, Gina</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Banerjee%2C+Susana%22">Banerjee, Susana</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gilbert%2C+Lucy%22">Gilbert, Lucy</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Gregorio%2C+Nikolaus%22">de Gregorio, Nikolaus</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tromp%2C+Jacqueline%22">Tromp, Jacqueline</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Jiuzhou%22">Wang, Jiuzhou</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Esteves%2C+Brooke%22">Esteves, Brooke</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Method%2C+Michael%22">Method, Michael</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+Gorp%2C+Toon%22">Van Gorp, Toon</searchLink><relatesTo>13</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. 2022 Supplement 1, Vol. 166, pS156-S157. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159029634
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0090-8258(22)01518-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S156
    Titles:
      – TitleFull: MIRASOL: A randomized, open-label, phase 3 study of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression (297)
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moore, Kathleen
      – PersonEntity:
          Name:
            NameFull: Konecny, Gottfried
      – PersonEntity:
          Name:
            NameFull: Martin, Lainie
      – PersonEntity:
          Name:
            NameFull: Floquet, Anne
      – PersonEntity:
          Name:
            NameFull: O'Malley, David
      – PersonEntity:
          Name:
            NameFull: Colombo, Nicoletta
      – PersonEntity:
          Name:
            NameFull: Mantia-Smaldone, Gina
      – PersonEntity:
          Name:
            NameFull: Banerjee, Susana
      – PersonEntity:
          Name:
            NameFull: Gilbert, Lucy
      – PersonEntity:
          Name:
            NameFull: de Gregorio, Nikolaus
      – PersonEntity:
          Name:
            NameFull: Tromp, Jacqueline
      – PersonEntity:
          Name:
            NameFull: Wang, Jiuzhou
      – PersonEntity:
          Name:
            NameFull: Esteves, Brooke
      – PersonEntity:
          Name:
            NameFull: Method, Michael
      – PersonEntity:
          Name:
            NameFull: Van Gorp, Toon
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 08
              Text: 2022 Supplement 1
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 00908258
          Numbering:
            – Type: volume
              Value: 166
          Titles:
            – TitleFull: Gynecologic Oncology
              Type: main
ResultId 1